Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The oxidative stress pathway in renal tissue represents an imbalance between the production of reactive oxygen and nitrogen species (ROS/RNS) and the kidney's antioxidant defense mechanisms. This imbalance leads to cellular damage, inflammation, and fibrosis, contributing to the pathogenesis of various kidney diseases, including AKI and CKD. Key components include ROS/RNS generating enzymes like NOX4, antioxidant enzymes (SOD, catalase, glutathione peroxidases), transcription factors like Nrf2 and NF-κB, and the autophagy pathway. Targeting this pathway involves modulating ROS/RNS production, enhancing antioxidant defenses, and regulating inflammatory signaling.
Modulation of ROS/RNS production, enhancement of antioxidant defenses, regulation of inflammatory signaling, modulation of autophagy
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidative Stress Pathway in Renal Tissue.